Ascendis Health Limited (JSE: ASC)

Market Cap	450.75M
Revenue (ttm)	1.47B
Net Income (ttm)	57.29M
Shares Out	626.05M
EPS (ttm)	0.09
PE Ratio	10.84
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	129,854
Open	72.00
Previous Close	72.00
Day's Range	68.00 - 72.00
52-Week Range	63.00 - 82.00
Beta	0.64
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 27, 2024

About Ascendis Health

Ascendis Health Limited, a health and wellness company, manufactures and distributes healthcare products in South Africa, Cyprus, Spain, Romania. It operates through Consumer Health, Pharma, and Medical Devices segments. The company offers natural supplements, multi-vitamin and mineral supplements, micronutrient supplements, nutraceutical supplements, vitamins, minerals, and homeopathic and herbal products under the Bettaway, Chela-Fer, Chela Preg, Chela Mag, Compounding Pharmacy, Junglevites, Menacal 7, Solal, and Vitaforce brand names. It als...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2008
• Employees: 14
• Stock Exchange: Johannesburg Stock Exchange
• Ticker Symbol: ASC

Financial Performance

In 2024, Ascendis Health's revenue was 1.47 billion, a decrease of -4.13% compared to the previous year's 1.54 billion. Earnings were 57.29 million, a decrease of -23.94%.